<DOC>
	<DOCNO>NCT02685436</DOCNO>
	<brief_summary>Wheezy infant test gastro-esophageal reflux disease ( GERD ) use combine multiple channel intraluminal impedance-pH ( MII-pH ) , esophagogastroduodenoscope ( EGD ) , lipid laden macrophage index BAL pepsin . Wheezy infant abnormal MII-pH reflux esophagitis give domperidone omeprazole re-evaluated symptom control exacerbation recurrence .</brief_summary>
	<brief_title>Role Pepsin Assay Wheezy Infants</brief_title>
	<detailed_description>Wheezy infant test gastro-esophageal reflux disease use combine MII-pH , EGD , LLMI BAL pepsin . Wheezy infant abnormal MII-pH reflux esophagitis give domperidone omeprazole 12 week re-evaluated symptom control wheeze exacerbation recurrence .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>Infants physician document 3 attack wheeze episode last 6 month persistent wheeze last one month Wheezy infant atopy ( allergic rhinoconjunctivitis eczema ) , prematurity ( le 34 week ) , abnormal neurological examination , congenital heart disease , airspace opacity chest radiography , trachealbronchial malformation , immune deficiency anatomical esophageal gastric malformation</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>